To receive Email alerts, click here.

GenVec Announces New Agreement with Global Pharmaceutical Company

08/06/10

GenVec Reports Second Quarter 2010 Financial Results

08/05/10

GenVec Announces Second Quarter 2010 Results Conference Call

07/29/10

GenVec Announces Research on New Vectors for Vaccines

07/26/10

GenVec Announces Engagement of Financial Advisor to Evaluate Strategic Alternatives

06/15/10

GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development

05/19/10

GenVec Receives NASDAQ Notice of Minimum Bid Price Non-Compliance

05/13/10

GenVec Reports First Quarter 2010 Financial Results

05/06/10

GenVec Announces First Quarter 2010 Results Conference Call

04/27/10

Encouraging Data from Malaria Study Presented

04/12/10

GenVec Discontinues Phase III Trial of TNFerade™

03/29/10